Pfizer Sues Mylan To Block Generic Sutent
Pfizer Inc. has lodged a patent infringement suit in an effort to prevent Mylan Inc. from introducing a generic version of blockbuster cancer drug Sutent....To view the full article, register now.
Already a subscriber? Click here to view full article